跳至主要内容
临床试验/JPRN-jRCT2080221452
JPRN-jRCT2080221452未知1 期

Phase I Clinical Study of RG7304 in Patients with Advanced Solid Tumors

Chugai Pharmaceutical Co., Ltd.0 个研究点目标入组 30 人开始时间: 2011年5月9日最近更新:

试验速览

阶段
1 期
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • Histologically or cytologically confirmed solid tumor
  • -Advanced cancer that did not respond to the standard therapy or for which a standard therapy has not been established
  • -PS of 0 to 1

排除标准

  • -Patients in whom an adverse reaction to the previous treatment persists at Grade 2 or higher.
  • -Patients with metastasis to the central nervous system that is accompanied by symptoms or requires treatment
  • -Clinically significant inflammatory condition is observed on the ocular surface

研究者

相似试验